Literature DB >> 30154115

IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia.

Ameera Alsadeq1, Lennart Lenk2,3, Anila Vadakumchery1, Antony Cousins4, Christian Vokuhl5, Ahmad Khadour1, Fotini Vogiatzi2,3, Felix Seyfried6, Lueder-Hinrich Meyer6, Gunnar Cario2,3, Elias Hobeika1, Klaus-Michael Debatin6, Christina Halsey4, Martin Schrappe2,3, Denis M Schewe2,3, Hassan Jumaa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30154115      PMCID： PMC6238156          DOI： 10.1182/blood-2018-04-844209

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  22 in total

Review 1.  Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis.

Authors:  Neel S Iyer; Lyn M Balsamo; Michael B Bracken; Nina S Kadan-Lottick
Journal:  Blood       Date:  2015-06-05       Impact factor: 22.113

2.  Interleukin-7 signaling as a therapeutic target in acute lymphoblastic leukemia.

Authors:  Angela Maria Savino; Shai Izraeli
Journal:  Expert Rev Hematol       Date:  2017-02-17       Impact factor: 2.929

3.  New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia.

Authors:  Vincent H J van der Velden; Daphne de Launaij; Jeltje F de Vries; Valerie de Haas; Edwin Sonneveld; Jane S A Voerman; Maaike de Bie; Tamas Revesz; Smadar Avigad; Allen E J Yeoh; Sigrid M A Swagemakers; Cornelia Eckert; Rob Pieters; Jacques J M van Dongen
Journal:  Br J Haematol       Date:  2015-12-21       Impact factor: 6.998

4.  Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS).

Authors:  Sarah Krause; Christian Pfeiffer; Susanne Strube; Ameera Alsadeq; Henning Fedders; Christian Vokuhl; Sonja Loges; Jonas Waizenegger; Isabel Ben-Batalla; Gunnar Cario; Anja Möricke; Martin Stanulla; Martin Schrappe; Denis M Schewe
Journal:  Blood       Date:  2014-11-26       Impact factor: 22.113

5.  Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study.

Authors:  M J Borowitz; D J Pullen; J J Shuster; D Viswanatha; K Montgomery; C L Willman; B Camitta
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

6.  Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.

Authors:  Frida Lundmark; Kristina Duvefelt; Ellen Iacobaeus; Ingrid Kockum; Erik Wallström; Mohsen Khademi; Annette Oturai; Lars P Ryder; Janna Saarela; Hanne F Harbo; Elisabeth G Celius; Hugh Salter; Tomas Olsson; Jan Hillert
Journal:  Nat Genet       Date:  2007-07-29       Impact factor: 38.330

7.  High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.

Authors:  Gunnar Cario; Shai Izraeli; Anja Teichert; Peter Rhein; Julia Skokowa; Anja Möricke; Martin Zimmermann; Andre Schrauder; Leonid Karawajew; Wolf-Dieter Ludwig; Karl Welte; Holger J Schünemann; Brigitte Schlegelberger; Martin Schrappe; Martin Stanulla
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

8.  The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

Authors:  A E Evans; E S Gilbert; R Zandstra
Journal:  Cancer       Date:  1970-08       Impact factor: 6.860

9.  IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.

Authors:  Sarah C Sasson; Sandy Smith; Nabila Seddiki; John J Zaunders; Adam Bryant; Kersten K Koelsch; Christopher Weatherall; Mee-Ling Munier; Ciara McGinley; Julie Yeung; Stephen P Mulligan; John Moore; David A Cooper; Sam Milliken; Anthony D Kelleher
Journal:  Cytokine       Date:  2010-01-08       Impact factor: 3.861

10.  The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.

Authors:  Mark T S Williams; Yasar M Yousafzai; Alex Elder; Klaus Rehe; Simon Bomken; Liron Frishman-Levy; Sigal Tavor; Paul Sinclair; Katie Dormon; Dino Masic; Tracey Perry; Victoria J Weston; Pamela Kearns; Helen Blair; Lisa J Russell; Olaf Heidenreich; Julie A E Irving; Shai Izraeli; Josef Vormoor; Gerard J Graham; Christina Halsey
Journal:  Blood       Date:  2016-02-11       Impact factor: 22.113
View more
  17 in total

1.  IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.

Authors:  Sara González-García; Marta Mosquera; Patricia Fuentes; Tiziana Palumbo; Adela Escudero; Antonio Pérez-Martínez; Manuel Ramírez; Anne E Corcoran; Maria L Toribio
Journal:  Blood       Date:  2019-12-12       Impact factor: 22.113

Review 2.  It Takes Three Receptors to Raise a B Cell.

Authors:  Kaitlin C McLean; Malay Mandal
Journal:  Trends Immunol       Date:  2020-05-22       Impact factor: 16.687

3.  Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.

Authors:  Paulina Richter-Pechańska; Joachim B Kunz; Tobias Rausch; Büşra Erarslan-Uysal; Beat Bornhauser; Viktoras Frismantas; Yassen Assenov; Martin Zimmermann; Margit Happich; Caroline von Knebel-Doeberitz; Nils von Neuhoff; Rolf Köhler; Martin Stanulla; Martin Schrappe; Gunnar Cario; Gabriele Escherich; Renate Kirschner-Schwabe; Cornelia Eckert; Smadar Avigad; Stefan M Pfister; Martina U Muckenthaler; Jean-Pierre Bourquin; Jan O Korbel; Andreas E Kulozik
Journal:  Leukemia       Date:  2022-05-18       Impact factor: 12.883

4.  Evaluation of multiplexed biomarkers in assessment of CSF infiltration in pediatric acute lymphoblastic leukemia.

Authors:  Neveen L Mikhael; Myriam Abo Seif H Gendi; Hoda Hassab; Elshaymaa A Megahed
Journal:  Int J Hematol Oncol       Date:  2019-08-12

Review 5.  Cerebrospinal Fluid Biomarkers in Childhood Leukemias.

Authors:  Chrysanthy Ikonomidou
Journal:  Cancers (Basel)       Date:  2021-01-24       Impact factor: 6.639

Review 6.  A narrative review of central nervous system involvement in acute leukemias.

Authors:  Dalma Deak; Nicolae Gorcea-Andronic; Valentina Sas; Patric Teodorescu; Catalin Constantinescu; Sabina Iluta; Sergiu Pasca; Ionut Hotea; Cristina Turcas; Vlad Moisoiu; Alina-Andreea Zimta; Simona Galdean; Jakob Steinheber; Ioana Rus; Sebastian Rauch; Cedric Richlitzki; Raluca Munteanu; Ancuta Jurj; Bobe Petrushev; Cristina Selicean; Mirela Marian; Olga Soritau; Alexandra Andries; Andrei Roman; Delia Dima; Alina Tanase; Olafur Sigurjonsson; Ciprian Tomuleasa
Journal:  Ann Transl Med       Date:  2021-01

Review 7.  Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer.

Authors:  Iva Marković; Savvas N Savvides
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

8.  Disrupting the leukemia niche in the central nervous system attenuates leukemia chemoresistance.

Authors:  Leslie M Jonart; Maryam Ebadi; Patrick Basile; Kimberly Johnson; Jessica Makori; Peter M Gordon
Journal:  Haematologica       Date:  2019-10-17       Impact factor: 9.941

Review 9.  IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.

Authors:  Mariana L Oliveira; Padma Akkapeddi; Daniel Ribeiro; Alice Melão; João T Barata
Journal:  Adv Biol Regul       Date:  2018-09-19

Review 10.  Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia.

Authors:  Fátima Bayón-Calderón; María L Toribio; Sara González-García
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.